Avacta Group Share News (AVCT)

Avacta Collaborating With Glythera To Develop Antibody Drugs

Avacta claims development could lead to early Zika diagnosis

(ShareCast News) - Avacta, biotherapeutics and research agent developer, reported on Wednesday it had identified three proteins which could be used to develop the first tests to diagnose early stages of the Zika virus. Avacta said it found three 'Affimer' proteins capable of binding to a form of sec

Avacta Identifies Affimer Proteins For Possible Zika Virus Tests

Avacta Forms Partnership With Mologic To Develop Point-Of-Care Tests

DIRECTOR DEALINGS: Avacta Chief Operating Officer Buys Shares

Avacta Making Good Progress On Programmes As Interim Loss Widens

Avacta Group Hails Milestone In Multi-Affimer Production

Earnings, Trading Statements Calendar - Week Ahead

Avacta appoints scientific advisory board

(ShareCast News) - Avacta Group established what it saw as one of the last pieces in the management puzzle to get its products towards the market, appointing professors Terence Rabbitts, Paul Moss and Adrian Hayday to form the company's scientific advisory board on Monday. The AIM-traded developer o

Avacta Gets Grant For Work To Help Reduce Use Of Animal Testing

Avacta Poaches Abcam's Cotrel For Chief Commercial Officer Role

Avacta Group Proposes 1-For-10 Share Consolidation (ALLISS)

Avacta Appoints Tony Gardiner As Chief Financial Officer

BROKER RATINGS SUMMARY: Investec Raises Senior To Buy From Hold

Avacta Full-Year Loss Widens As It Ramps Up Affimer Investment